BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 11822005)

  • 1. Ulcer and gastritis.
    Wu JC; Sung JJ
    Endoscopy; 2002 Feb; 34(2):104-10. PubMed ID: 11822005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Secondary and primary prophylaxis of gastropathy associated with nonsteroidal antiinflammatory drugs or low-dose-aspirin: a review based on four clinical scenarios].
    Limmer S; Ittel TH; Wietholtz H
    Z Gastroenterol; 2003 Aug; 41(8):719-28. PubMed ID: 12910426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ulcers and gastritis.
    Kashiwagi H
    Endoscopy; 2003 Jan; 35(1):9-14. PubMed ID: 12510220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Helicobacter pylori: therapeutic targets.
    Louw JA; Marks IN
    Yale J Biol Med; 1998; 71(2):113-7. PubMed ID: 10378356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peptic ulcer disease today.
    Yuan Y; Padol IT; Hunt RH
    Nat Clin Pract Gastroenterol Hepatol; 2006 Feb; 3(2):80-9. PubMed ID: 16456574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Helicobacter pylori infection as a cause of gastritis, duodenal ulcer, gastric cancer and nonulcer dyspepsia: a systematic overview.
    Veldhuyzen van Zanten SJ; Sherman PM
    CMAJ; 1994 Jan; 150(2):177-85. PubMed ID: 8287340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Helicobacter pylori and benign upper digestive disease.
    Lai LH; Sung JJ
    Best Pract Res Clin Gastroenterol; 2007; 21(2):261-79. PubMed ID: 17382276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eradication therapy of Helicobacter pylori directly induces apoptosis in inflammation-related immunocytes in the gastric mucosa--possible mechanism for cure of peptic ulcer disease and MALT lymphoma with a low-grade malignancy.
    Ohara T; Kanoh Y; Higuchi K; Arakawa T; Morisita T
    Hepatogastroenterology; 2003; 50(51):607-9. PubMed ID: 12828043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Helicobacter pylori and non-steroidal anti-inflammatory drugs: does infection affect the outcome of NSAID therapy?
    McCarthy DM
    Yale J Biol Med; 1998; 71(2):101-11. PubMed ID: 10378355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meta-analysis: role of Helicobacter pylori eradication in the prevention of peptic ulcer in NSAID users.
    Vergara M; Catalán M; Gisbert JP; Calvet X
    Aliment Pharmacol Ther; 2005 Jun; 21(12):1411-8. PubMed ID: 15948807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Helicobacter pylori and non-malignant diseases.
    Rokkas T; Simsek I; Ladas S
    Helicobacter; 2007 Oct; 12 Suppl 1():20-2. PubMed ID: 17727456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eradication of Helicobacter pylori does not reduce the incidence of gastroduodenal ulcers in patients on long-term NSAID treatment: double-blind, randomized, placebo-controlled trial.
    de Leest HT; Steen KS; Lems WF; Bijlsma JW; van de Laar MA; Huisman AM; Vonkeman HE; Houben HH; Kadir SW; Kostense PJ; van Tulder MW; Kuipers EJ; Boers M; Dijkmans BA
    Helicobacter; 2007 Oct; 12(5):477-85. PubMed ID: 17760715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Helicobacter pylori and non-malignant diseases.
    Furuta T; Delchier JC
    Helicobacter; 2009 Sep; 14 Suppl 1():29-35. PubMed ID: 19712165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can lansoprazole, amoxicillin, and clarithromycin combination still be used as a first-line therapy for eradication of helicobacter pylori?
    Güliter S; Keleş H; Ozkurt ZN; Cengiz DU; Kolukisa E
    Turk J Gastroenterol; 2005 Mar; 16(1):29-33. PubMed ID: 16252185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Helicobacter pylori and nonmalignant diseases.
    Kuipers EJ; Malfertheiner P
    Helicobacter; 2004; 9 Suppl 1():29-34. PubMed ID: 15347303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of nonsteroidal anti-inflammatory drugs (NSAID) with Helicobacter pylori in the stomach of humans and experimental animals.
    Brzozowski T; Konturek PC; Sliwowski Z; Kwiecień S; Drozdowicz D; Pawlik M; Mach K; Konturek SJ; Pawlik WW
    J Physiol Pharmacol; 2006 Sep; 57 Suppl 3():67-79. PubMed ID: 17033106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends in the prevalence of peptic ulcer disease and Helicobacter pylori infection in family physician-referred uninvestigated dyspeptic patients in Hong Kong.
    Xia B; Xia HH; Ma CW; Wong KW; Fung FM; Hui CK; Chan CK; Chan AO; Lai KC; Yuen MF; Wong BC
    Aliment Pharmacol Ther; 2005 Aug; 22(3):243-9. PubMed ID: 16091062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Helicobacter pylori-related diseases: dyspepsia, ulcers and gastric cancer].
    Gisbert JP
    Gastroenterol Hepatol; 2011 Oct; 34 Suppl 2():15-26. PubMed ID: 22330153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guidelines in the medical treatment of Helicobacter pylori infection.
    Dzieniszewski J; Jarosz M
    J Physiol Pharmacol; 2006 Sep; 57 Suppl 3():143-54. PubMed ID: 17033112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ulcers and gastritis.
    Kashiwagi H
    Endoscopy; 2005 Feb; 37(2):110-5. PubMed ID: 15692925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.